Skip to main content
. 2018 Jul 2;18:93. doi: 10.1186/s12883-018-1096-2

Table 1.

Comparison of clinical characteristics between the non-WMH group and WMH group

Non-WMH group (n = 45) WMH group
(n = 24)
P-value
Age (year, mean ± SD) 30.6 ± 10.4 39.0 ± 7.9 < 0.001*
Gender 0.592
 Female, n (%) 33 (73.3%) 19 (79.2%)
 Male, n (%) 12 (26.7%) 5 (20.8%)
BMI (kg/m2, mean ± SD) 20.7 ± 2.9 21.8 ± 2.2 0.127
Hypertension, n (%) 2 (4.4%) 3 (12.5%) 0.458
Smoking, n (%) 5 (11.1%) 3 (12.5%) 1.000
Oral contraceptive use, n (%) 1 (2.9%) 1 (5.3%) 1.000
Headache characteristics
 Aura, n (%) 14 (31.1%) 5 (20.8%) 0.363
 Disease duration (month, quartile) 84.0 (42.0, 198.0) 180.0 (75.0, 297.0) 0.013*
 Attack frequency (day/month, quartile) 3.0 (2.0, 7.0) 4.0 (2.0, 10.0) 0.465
 Attack duration (hour, quartile) 5.0 (3.0, 10.0) 9.5 (4.0, 24.0) 0.172
 Visual analogue scale, mean ± SD 7.0 ± 1.9 7.8 ± 1.5 0.080
Accompany symptoms
 Nausea, n (%) 37 (84.1%) 21 (87.5%) 0.983
 Vomiting, n (%) 28 (63.6%) 15 (62.5%) 0.926
 Photophobia, n (%) 32 (72.7%) 18 (75.0%) 0.839
 Phonophobia, n (%) 33 (75.0%) 18 (75.0%) 1.000
 Dizziness, n (%) 21 (47.7%) 13 (54.2%) 0.612
Family history of migraine, n (%) 26 (57.8%) 11 (45.8%) 0.343
SDS scores (quartile) 42 (36, 56) 44.5 (37.3, 56.8) 0.653

*A significance level, P < 0.05; SD standard deviation, BMI body mass index